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Background/aim: Diabetes mellitus (DM) could influence various organs, especially the eyes, kidneys, nerves, heart, and blood vessels,
and finally results in many irreversible disease-related complications. In this paper, the association between reflux, swallowing, and voice
symptoms in patients with DM and the possible effect of diabetic complications on these symptoms were investigated.
Materials and methods: A total of 179 patients with diabetes were included to the study. Three self-reported questionnaires; Reflux
Symptom Index (RSI), Eating Assessment Tool-10 (EAT-10), and Voice Handicap Index-10 (VHI-10) were administrated to the patients
and, their association with DM-related neuropathy and nephropathy were examined.
Results: The scores of each questionnaire were significantly correlated with each other (p < 0.001). There was not any statistically
significant association between the score of T-RSI and the diabetic complications (p = 0.077), while a statistically significant association
was found between the T-EAT-10 score and neuropathy (p < 0.001). Neither neuropathy nor nephropathy alone had an association with
the T-VHI-10 score. However, the presence of nephropathy and neuropathy together was found to be associated with the T-VHI-10
score (p = 0.027).
Conclusion: It is possible to conclude that gastrointestinal symptoms such as reflux, dysphonia, and dysphagia are associated with each
other and they may possibly be related to the microvascular complications of DM. The clinicians should be aware of the possible reflux,
voice, and swallowing complaints and also inquire about the presence of neuropathy and nephropathy in the diabetic population.
Key words: Diabetic complications, reflux, swallowing disorders, voice disorders

1. Introduction
Diabetes mellitus (DM) is a metabolic disorder
characterized by chronic hyperglycemia and its incidence
and prevalence are increasing all over the world. The
prevalence was predicted to be 9.3% (463 million people) in
2019, 10.2% (578 million) in 2030 and 10.9% (700 million)
in 2045 by The International Diabetes Federation (IDF)
[1]. Currently, DM is one of the most common chronic
diseases and a growing public health concern globally due
to its high rate of morbidity and mortality [2,3].
Diabetic complications which are classified as
microvascular or macrovascular are a major cause
of morbidity and mortality. While microvascular
complications consist of neuropathy, nephropathy,
and retinopathy; macrovascular complications include
peripheral vascular disease, cerebrovascular disease, and
cardiovascular disease [4]. DM-related complications
like diabetic neuropathy are considered to be the primary
reason for gastrointestinal (GI) tract symptoms [5]. It

is well established that GI symptoms such as; reflux,
dysphagia, vomiting, nausea, heartburn, abdominal pain
or discomfort, diarrhea or constipation, and bloating are
more common among patients with diabetes than the
general population. [6–8]. Particularly, the prevalence of
gastroesophageal reflux disease (GERD) is relatively high
in patients with DM and it is reported to be associated
with the microvascular complications of DM [9,10].
On the other hand, in a study by Hamdan et al. [11],
laryngopharyngeal signs and symptoms such as; throat
clearing, globus, vocal fatigue, and dysphonia were found
to be prevalent in patients with GERD. Also, a number of
studies have addressed that laryngopharyngeal symptoms
may be predictors of gastroesophageal diseases and GERD
and they are associated with extraesophageal reflux disease,
termed laryngopharyngeal reflux (LPR) [11,12]. Besides, in
the diabetic population, patients were reported to be more
likely to have LPR and phonatory symptoms compared
with controls [13,14]. Briefly, diabetic complications may
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be an important etiological cofactor in the development of
GI tract symptoms, particularly in reflux, dysphagia, and
dysphonia.
Self-reported questionnaires are used to assess the
impacts of health problems on the quality of life of patients.
Reliability, convenience, rapid administration time,
noninvasiveness, and low-cost are the primary reasons for
using questionnaires in clinical settings [15]. In the present
study, we used three validated self-reported questionnaires
namely, The Turkish Reflux Symptom Index (T-RSI), The
Turkish Eating Assessment Tool-10 (T-EAT-10), The
Turkish Voice Handicap Index-10 (T-VHI-10) to collect
data about the patients’ reflux, swallowing, and voice
complaints, respectively. To the best of our knowledge,
there is no study investigating the association between
reflux, dysphagia, and dysphonia in DM by using the
above-mentioned questionnaires.
Specifically, we hypothesize that the score of the
questionnaires are correlated with each other and diabetic
complications are associated with abnormal questionnaire
scores. The primary aim of the current study is to
investigate the association between reflux, swallowing,
and voice complaints in patients with diabetes. We
further aimed to identify the possible effect of diabetic
complications, namely, neuropathy and nephropathy, on
reflux, dysphonia, and dysphagia symptoms in the target
population.
2. Materials and methods
2.1. Participants
An observational cross-sectional research model was
used to collect data from the adult patients with DM, who
were followed up at Gazi University Diabetes-Obesity
Outpatient Clinic. A total of 179 subjects (76 males and
103 females) with a mean age of 55.16 ± 10.21 and a range
of 24–81 years were recruited to the present study between
January 2019 and May 2019. The subjects with any
additional diagnosis that could affect swallowing and voice
functions, those with a prior history of head and neck or
GI tract surgery, and those who are ineligible to fill in the
questionnaires were excluded from the study. However,
for the patients who were able to understand and answer
the questions, but unable to fill in the questionnaires on
their own, each item of the questionnaires was read to
them by the researchers. Ethical approval was gained from
the Gazi University Research Ethics Committee. Prior to
enrollment, a written informed consent was required from
all subjects.
2.2. Data collection
The following characteristics for each patient were noted:
age, sex, body mass index (BMI) based on self-reported
height and weight, duration of DM, the level of HgA1c, and
presence of DM-related neuropathy and nephropathy. In

our hospital, a clinically based diagnosis of neuropathy is
routinely made by an endocrine physician at the time of the
clinical visits. Positive sensory findings such as numbness,
tingling, burning, and pain in the limbs are considered and
noted for the presence of neuropathy. For the diagnosis of
nephropathy, proteinuria and microalbuminuria levels
and renal echography are regularly made and recorded
in patients’ charts. In the current study, the presence of
both neuropathy and nephropathy were acquired from
the electronic medical record of each participant. Next,
the patients were required to complete the following three
questionnaires, namely: Reflux Symptom Index (RSI)
[16], Eating Assessment Tool-10 (EAT-10) [17], and Voice
Handicap Index-10 (VHI-10) [18] under the supervision of
the first two authors. Validation and cultural adaptation of
the Turkish version of the above-mentioned questionnaires
are available in the current literature [19–21].
2.3. The questionnaires
The Turkish Reflux Symptom Index (T-RSI) [19] is a
reliable and valid self-administered clinical tool for the
assessment of LPR. It consists of nine items and each item
score ranges from 0 (no problem) to 5 (severe problem).
While a maximum score of 45 indicates the most severe
symptoms, a score greater than 13 is considered to be
abnormal.
The Turkish Eating Assessment Tool-10 (T-EAT-10)
[20] is a practical and easily self-administered, 10-item
swallowing screening tool. Each item has a 5-point scale
ranging from 0 (no difficulty) to 4 (severe difficulty) and
a score of 3 or higher is considered to be an abnormal
swallowing function.
The Turkish Voice Handicap Index-10 (T-VHI-10)
[21], was used for self-evaluation of voice problems. The
questionnaire consists of 10 voice-related items, with five
possible answers: 0–never; 1–almost never; 2–sometimes;
3–almost always; and 4–always. The higher score means
the higher level of dysphonia and the subjects with a cutoff
score of > 11 are considered to have voice-related problems
[22].
2.4. Statistical analysis
The normality of data distribution was examined using
the visual (histogram and probability graphs) and
analytical methods (Kolmogorov-Smirnov/Shapiro-Wilk
tests). While all categorical variables were presented
as percentages, all normally distributed variables were
presented as mean and standard deviations (SD) and all
skewed variables were presented as median (minimummaximum value). Spearman correlation was used to
assess the level of correlation between scores of the
questionnaires and other clinical variables. A chi-square
test was applied to investigate the association between
diabetic complications and scores of the questionnaires.
All data analyses were performed using Statistical Package
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for Social Sciences (SPSS) version 22.0 (SPSS Inc. Chicago,
USA), with the level of significance at p < 0.05.
3. Results
In all 179 subjects participated to the study, the median
duration of DM was 8 years (range: 1 to 41 years) and
the median value of HgA1c was 7.1 (range: 4.9 to 13.8).
Out of the total 179 patients, 44 (24.6%) and 26 (14.5%)
had diabetic neuropathy and diabetic nephropathy,
respectively. The detailed patients’ characteristics and
clinical findings are given in Table 1.
Thirteen patients (7.3%) had an abnormal T-RSI score
(a score of >13) and 36 (20.1%) of the subjects had an
abnormal T-EAT-10 score (a score of ≥3). The number of
the participants with an abnormal score of >11 from the
T-VHI-10 questionnaire was 7 (3.9%) (See Table 2 for more
details). The distributions of the scores obtained from each
questionnaire are illustrated in Figures 1, 2, and 3.
The Spearman analyses presented that duration of DM
and age (r: 0.320) and HgA1c (r: 0.212) were correlated
to each other. Among the questionnaires, only T-VHI-10
scores were correlated with age (r: –0.106) and duration
of the DM (r: 0.002). However, no correlation was found
between the HgA1c level and all three questionnaires. It was
seen that scores of each questionnaire were significantly
correlated with each other (p < 0.001) (Table 3).
As it is seen in Table 4, there was not any statistically
significant association between the score of T-RSI and the
diabetic complications (p = 0.077), while a statistically
significant association was found between the T-EAT-10
score and neuropathy (p < 0.001). Among the diabetic

complications, neither neuropathy nor nephropathy alone
had an association with the T-VHI-10 score. However,
the presence of nephropathy and neuropathy together
was found to be associated with the T-VHI-10 score (p =
0.027).
4. Discussion
Most of the patients with diabetes have insulin defects
in insulin secretion, insulin action, or both [23]. These
metabolic changes if not controlled lead to mortalities
and morbidities in various organs, especially in the eyes,
kidneys, nerves, heart, and blood vessels [23,24]. While
the microvascular complications start to develop with the
onset of hyperglycemia, the macrovascular complications
develop at the onset of insulin resistance.
Neuropathy is one of the most common microvascular
complications of diabetes. In clinic-based studies, the
prevalence of neuropathy in people with DM has ranged
from 16% to 26% [25–27]. As it is known, nephropathy
is another DM-related complication that is commonly
encountered in patients with diabetes and its incidence was
stated to be in the range of 6.7% to 42.5% [28,29]. In line
with the literature, the present study revealed that 24.6%
and 14.5% of the total 179 participants had neuropathy
and nephropathy respectively.
To date, a growing number of studies have been conducted
to investigate the voice and swallowing functions in the
diabetic population [14,30–33]. However, to the best of our
knowledge, this is the first study to attempt to understand
the possible effect of neuropathy and nephropathy, on

Table 2. Scores of the questionnaires.
Table 1. Patients’ characteristics and clinical findings.
Variables

DM
N = 179

Age, years (mean ± sd)

55.16 ± 10.21

Gender, n (%)*
Female
Male

103 (57.5)
76 (42.5)

BMI, kg/m2 median (range)

29.7 (19.5–53.7)

Duration of diabetes, years median (range) 8 (1–40)
HgA1c, % median (range)

7.1 (4.9–13.8)

Nephropathy + neuropathy, n (%)

14 (7.8)

Nephropathy, n (%)

12 (6.7)

Neuropathy, n (%)

30 (16.8)

No complications, n (%)

123 (68.7)

DM, Diabetes mellitus; *, Column percentage; BMI, Body mass
index; HgA1c, Hemoglobin A1C
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Variables

DM
n = 179

T-RSI score, median (range)

0 (0–24)

T-RSI score, n (%)*
Normal (score ≤ 13)
Abnormal (score > 13)

166 (92.7)
13 (7.3)

T-Eat-10 score, median (range)

0 (0–25)

T-Eat-10 score, n (%)
Normal (score < 3)
Abnormal (score ≥ 3)

143 (79.9)
36 (20.1)

T-VHI-10 score, median (range)

0 (0–24)

T-VHI-10 score, n (%)
Normal (score ≤ 11)
Abnormal (score > 11)

172 (96.1)
7 (3.9)

*, Column percentage; T-Eat-10, Turkish Eating Assessment
Tool-10; T-RSI, Turkish Reflux Symptom Index; T-VHI-10,
Turkish Voice Handicap Index-10
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Figure 1. Distribution of the Turkish-Reflux Symptom Index scores.

Figure 2. Distribution of the Turkish-Eating Assessment Tool-10 scores.

reflux, dysphonia, and dysphagia symptoms in DM patients.
On the other hand, there is not any report in the literature
about the association between reflux, swallowing, and voice
complaints in patients with diabetes.

Hamdan et al. [14] studied the prevalence of phonatory
symptoms in patients with type 2 DM and reported that
diabetic patients are more likely to have vocal straining and
hoarseness compared to controls. In another research by
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Figure 3. Distribution of the Turkish-Voice Handicap Index-10 scores.
Table 3. Spearman correlation between scores of the questionnaires and other clinical variables.
Age

Duration of DM HgA1c

r

p-value

Age

-

-

Duration of DM

0.320

p-value r

T-RSI score

p-value r

T-EAT-10 score

p-value r

p-value r

< 0.001

-

-

HgA1c

NS

0.212

0.004

T-RSI score

NS

NS

NS

-

-

T-EAT-10 score

NS

NS

NS

0.371

< 0.001

-

-

NS

0.378

< 0.001

0.398

< 0.001

T-VHI-10 score

-0.106 0.033

-0.225 0.002

-

T-VHI-10 score
p-value

-

-

-

NS, Not significant; DM, Diabetes mellitus; HgA1c, Hemoglobin A1C; T-Eat-10, Turkish Eating Assessment Tool-10; T-RSI, Turkish
Reflux Symptom Index; T-VHI-10, Turkish Voice Handicap Index-10

Hamdan et al. [31], they compared the vocal characteristics
of patients with type 2 DM with healthy controls. Despite
no statistically significant difference in any of the perceptual
evaluation parameters namely; grade, roughness,
breathiness, asthenia, and straining (GRBAS) between the
groups, the mean scores were all higher in the diseased
group except for roughness. In both studies, the presence of
neuropathy was stated to affect vocal health. In the current
study, the presence of nephropathy and neuropathy together
was found to be associated with the T-VHI-10 score (p =
0.027). Accordingly, the T-VHI-10 scores of individuals
who have nephropathy and neuropathy together were high.
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When the effect of neuropathy and nephropathy
on swallowing function was considered, there was a
statistically significant association between the T-EAT-10
score and neuropathy but not for nephropathy. In a
previous study that was completed with 121 participants
with Type 2 DM, Gölaç et al. [30] reported that T-EAT-10
score was significantly associated with neuropathy and
reflux complaint which was similar to our findings.
Recent evidence suggests that the prevalence of
GERD is relatively high in patients with DM and it is
associated with LPR [11,12]. Also, in several studies,
reflux is reported to be associated with DM-related

GÖLAÇ et al. / Turk J Med Sci
Table 4. Association between the diabetic complications and scores of the questionnaires.
Nephropathy +
neuropathy
(n = 14)

Nephropathy
(n = 12)

Neuropathy
(n = 30)

No complications
(n = 123)

11 (6.6)a
1 (7.7)a

25 (15.1)a
5 (38.5)a

118 (71.1)a
5 (38.5)a

0.077

p-value

T-RSI score, n (%)*
Normal (score ≤ 13)
Abnormal (score > 13)

12 (7.2)a
2 (15.3)a

T-Eat-10 score, n (%)
Normal (score < 3)
Abnormal (score ≥ 3)

8 (5.6)a
6 (16.7)a

10 (7.0)a,b
2 (5.6)a,b

13 (9.1)a
17 (47.2)a

112 (78.3)b
11 (30.6)b

< 0.001

12 (7.0)a
2 (28.6)a

12 (7.0) a,b
0 (0) a,b

27 (15.7) a,b
3 (42.8) a,b

121 (70.3)b
2 (28.6)b

0.027

T-VHI-10 score, n (%)
Normal (score ≤ 11)
Abnormal (score > 11)

*, Row percentage; T-Eat-10, Turkish Eating Assessment Tool-10; T-RSI, Turkish Reflux Symptom Index; T-VHI-10, Turkish
Voice Handicap Index-10
Each superscript letter denotes a subset of categories whose column proportions do not differ significantly from each other at
the 0.05 level (categories that do not share a common superscript letter are significantly different from each other).

microvascular complications [9,10]. However, our
findings did not correlate well with the previous literature
that no statistically significant association was found
between the diabetic complications and T-RSI score.
The low number of participants was considered to be the
probable reason and it is thought that an association could
be found in a study with more participants. Additionally,
the proportion of patients having reflux symptoms
was 7.3%, which seems to be less than the reported
prevalence (25%–41%) in the literature [34,35]. To date,
many studies have been conducted to investigate the
effectiveness of diet modification and lifestyle change on
the improvement of symptoms, signs, and voice quality
in reflux disease [36–39]. It is generally believed that
modification in dietary contents of the patients appears
to have beneficial effects on the symptoms and findings of
reflux and yields rapid and substantial results in treating
reflux-related complaints. In the current study, there is no
data regarding the diet contents of the patients which may
likely influence the reflux-related signs and symptoms.
Therefore, the reason for the low prevalence of reported
reflux in our patient group might be due to the diet
contents of the participants.
It has been stated in many studies that the presence
of reflux alone may cause voice and/or swallowing
complaints [40–42]. In the present study, the scores of
each questionnaire were significantly correlated with each
other. The probable reason for this correlation is that all
the items of the questionnaires reveal the findings related
to GI tract symptoms and/or discomforts. In the validity
and reliability study of the EAT-10, the mean score of the
questionnaire was reported to be high for those with reflux

disease and voice disorder. Also, no significant difference
was found in the EAT-10 score of those with a voice
disorder and those with reflux disease. Therefore, patients
with diabetes, particularly those who have reflux should be
considered about the probable dysphonia and dysphagia.
The present study has several limitations that warrant
consideration. First, the presence of neuropathy and
nephropathy was determined with the clinical symptoms
and signs. It is of importance to use objective methods in
the diagnosis of these microvascular complications that
can give more accurate results. Second, this study was
designed as an observational cross-sectional research
model and a relatively small subgroup of patients who had
reflux and voice complaints were included in data analyses.
Thus, the causal association between variables is not firmly
established in this study. Further studies with a control
group and with a relatively larger sample size are necessary
to determine whether these findings can be generalized to
the diabetic population.
From the research that has been conducted, it is
possible to conclude that GI symptoms such as reflux,
dysphonia, and dysphagia are associated with each other
in patients with DM. Also, these symptoms may possibly
be related to the microvascular complications of diabetes,
such as neuropathy and nephropathy. Therefore, in the
diabetic population, the clinicians should be aware of the
possible reflux, voice, and swallowing complaints and also
inquire about the presence of neuropathy and nephropathy.
Because the self-administrated questionnaires are easy to
use and cost-effective in clinical practice, they can be used
as a screening tool to detect reflux, voice, and swallowingrelated problems of patients with diabetes.
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